Therefore, reduction in SMN protein levels by ~65% (Zpr1Hb9MNΔ) and ~50% (Zpr1ChATMNΔ) suggest development of severe to moderate SMA-like disease in Zpr1 mutant mice. This evidence concerns the gene ZPR1 and proximal spinal muscular atrophy.